Eqis Capital Management, Inc. Checkpoint Therapeutics, Inc. Transaction History

Eqis Capital Management, Inc.

  • $1.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022
SELL
$1.02 - $10.6 $714 - $7,420
-700 Reduced 3.76%
17,911 $0
Q2 2022

Aug 08, 2022
SELL
$0.97 - $1.77 $244 - $446
-252 Reduced 1.34%
18,611 $19,000
Q1 2022

May 16, 2022
BUY
$1.53 - $3.25 $28,860 - $61,304
18,863 New
18,863 $33,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $351M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email